{"id":72499,"date":"2026-08-14T12:10:06","date_gmt":"2026-08-14T04:10:06","guid":{"rendered":"https:\/\/flcube.com\/?p=72499"},"modified":"2026-08-14T12:10:08","modified_gmt":"2026-08-14T04:10:08","slug":"acrobiosystems-and-bailinke-pharmaceutical-form-strategic-partnership-to-build-ai-empowered-affinity-purification-solutions","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=72499","title":{"rendered":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\"><strong>ACROBiosystems Co., Ltd.<\/strong> (<a href=\"https:\/\/www.google.com\/finance\/beta\/quote\/301080:SHE\">SHE: <strong>301080<\/strong><\/a>) and <strong>Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd.<\/strong> have entered into a <strong>strategic partnership<\/strong> to establish a long\u2011term strategic relationship focused on <strong>AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins<\/strong>. The two companies will jointly build a next\u2011generation <strong>affinity purification<\/strong> solution that integrates <strong>&#8220;upstream AI protein design + downstream affinity resins.&#8221;<\/strong><\/p>\n\n\n\n<h2 id=\"h-deal-snapshot\" class=\"wp-block-heading\">Deal Snapshot<\/h2>\n\n\n\n<figure class=\"wp-block-table\"><table class=\"has-fixed-layout\"><thead><tr><th>Item<\/th><th>Detail<\/th><\/tr><\/thead><tbody><tr><td><strong>Partners<\/strong><\/td><td>ACROBiosystems Co., Ltd. (301080) &amp; Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd.<\/td><\/tr><tr><td><strong>Agreement Type<\/strong><\/td><td>Long\u2011term strategic partnership<\/td><\/tr><tr><td><strong>Announcement Date<\/strong><\/td><td>13 Aug 2026<\/td><\/tr><tr><td><strong>Focus Areas<\/strong><\/td><td>AI\u2011empowered affinity purification ligands; affinity chromatography resins<\/td><\/tr><tr><td><strong>Integrated Solution<\/strong><\/td><td>Upstream AI protein design + downstream affinity resins<\/td><\/tr><tr><td><strong>Financial Terms<\/strong><\/td><td>Not disclosed<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n<h2 id=\"h-technology-scope-ai-empowered-affinity-purification\" class=\"wp-block-heading\">Technology Scope \u2013 AI\u2011Empowered Affinity Purification<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Core Objective:<\/strong> Develop next\u2011generation <strong>affinity purification ligands<\/strong> and <strong>affinity chromatography resins<\/strong> empowered by artificial intelligence.<\/li>\n\n\n\n<li><strong>Integration Model:<\/strong> Combine <strong>upstream AI protein design<\/strong> with <strong>downstream affinity resins<\/strong> into a single, integrated affinity purification solution.<\/li>\n\n\n\n<li><strong>Process Significance:<\/strong> <strong>Affinity purification<\/strong> is one of the most critical core processes in <strong>antibody and biopharmaceutical manufacturing<\/strong>; its technological level directly impacts <strong>production efficiency, product quality, and manufacturing costs<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-company-profile-acrobiosystems\" class=\"wp-block-heading\">Company Profile \u2013 ACROBiosystems<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Founded:<\/strong> 2010; listed on the <strong>ChiNext market in 2021<\/strong> (Stock Code: <strong>301080<\/strong>)<\/li>\n\n\n\n<li><strong>Vision:<\/strong> To become a <strong>cornerstone platform enterprise<\/strong> providing critical biological reagents, solutions, and innovative business models for the global biopharmaceutical and healthcare industries<\/li>\n\n\n\n<li><strong>Global Footprint:<\/strong> Operations across <strong>Asia, North America, and Europe<\/strong>, with offices, R&amp;D centers, and manufacturing bases in <strong>16 cities<\/strong> across countries including <strong>China, the United States, and Switzerland<\/strong><\/li>\n<\/ul>\n\n\n\n<h2 id=\"h-market-impact-amp-outlook\" class=\"wp-block-heading\">Market Impact &amp; Outlook<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>AI Meets Downstream Processing:<\/strong> The partnership applies <strong>AI protein design<\/strong> to affinity ligands \u2014 an area where rational engineering has historically been slow \u2014 potentially accelerating ligand optimization and resin performance.<\/li>\n\n\n\n<li><strong>Cost and Quality Leverage:<\/strong> Because affinity purification directly drives <strong>production efficiency, product quality, and manufacturing costs<\/strong>, improvements in ligand\/resin technology carry direct commercial value for antibody and biopharmaceutical manufacturers.<\/li>\n\n\n\n<li><strong>Platform Synergy:<\/strong> <strong>ACROBiosystems&#8217;<\/strong> global reagent platform and manufacturing infrastructure complement <strong>Bailinke Pharmaceutical&#8217;s<\/strong> ligand engineering capabilities, creating an end\u2011to\u2011end solution from design to resin.<\/li>\n\n\n\n<li><strong>Strategic Positioning:<\/strong> The integrated &#8220;design + resin&#8221; offering positions the partnership to serve the growing demand for cost\u2011effective, high\u2011quality downstream processing across the global biopharmaceutical industry.<\/li>\n<\/ul>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Forward\u2011Looking Statements<\/strong><br>This brief contains forward\u2011looking statements regarding the strategic partnership between ACROBiosystems and Bailinke Pharmaceutical, the development of AI\u2011empowered affinity purification solutions, and potential commercial applications. Actual results may differ due to risks including technology development timelines, market adoption, and competitive dynamics in biopharmaceutical process technologies.<a href=\"https:\/\/flcube.com\/\">-Fineline Info &amp; Tech<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into&#8230;<\/p>\n","protected":false},"author":1,"featured_media":72500,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_feature_clip_id":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2},"jetpack_post_was_ever_published":false},"categories":[7,10],"tags":[2468,99,4898,2467],"class_list":["post-72499","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-acrobiosystems","tag-ai","tag-bailinke-pharmaceutical-technology","tag-she-301080"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.5 (Yoast SEO v28.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into a strategic partnership to establish a long\u2011term strategic relationship focused on AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins. The two companies will jointly build a next\u2011generation affinity purification solution that integrates &quot;upstream AI protein design + downstream affinity resins.&quot;\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=72499\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions\" \/>\n<meta property=\"og:description\" content=\"ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into a strategic partnership to establish a long\u2011term strategic relationship focused on AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins. The two companies will jointly build a next\u2011generation affinity purification solution that integrates &quot;upstream AI protein design + downstream affinity resins.&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=72499\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2026-08-14T04:10:06+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-08-14T04:10:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions\",\"datePublished\":\"2026-08-14T04:10:06+00:00\",\"dateModified\":\"2026-08-14T04:10:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499\"},\"wordCount\":422,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1402.webp\",\"keywords\":[\"ACROBiosystems\",\"AI\",\"Bailinke Pharmaceutical Technology\",\"SHE: 301080\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72499#respond\"]}],\"copyrightYear\":\"2026\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=72499\",\"name\":\"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1402.webp\",\"datePublished\":\"2026-08-14T04:10:06+00:00\",\"dateModified\":\"2026-08-14T04:10:08+00:00\",\"description\":\"ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into a strategic partnership to establish a long\u2011term strategic relationship focused on AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins. The two companies will jointly build a next\u2011generation affinity purification solution that integrates \\\"upstream AI protein design + downstream affinity resins.\\\"\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=72499\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1402.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2026\\\/08\\\/1402.webp\",\"width\":1080,\"height\":608,\"caption\":\"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=72499#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions - Insight, China&#039;s Pharmaceutical Industry","description":"ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into a strategic partnership to establish a long\u2011term strategic relationship focused on AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins. The two companies will jointly build a next\u2011generation affinity purification solution that integrates \"upstream AI protein design + downstream affinity resins.\"","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=72499","og_locale":"en_US","og_type":"article","og_title":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions","og_description":"ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into a strategic partnership to establish a long\u2011term strategic relationship focused on AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins. The two companies will jointly build a next\u2011generation affinity purification solution that integrates \"upstream AI protein design + downstream affinity resins.\"","og_url":"https:\/\/flcube.com\/?p=72499","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2026-08-14T04:10:06+00:00","article_modified_time":"2026-08-14T04:10:08+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=72499#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=72499"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions","datePublished":"2026-08-14T04:10:06+00:00","dateModified":"2026-08-14T04:10:08+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=72499"},"wordCount":422,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=72499#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp","keywords":["ACROBiosystems","AI","Bailinke Pharmaceutical Technology","SHE: 301080"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=72499#respond"]}],"copyrightYear":"2026","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=72499","url":"https:\/\/flcube.com\/?p=72499","name":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=72499#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=72499#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp","datePublished":"2026-08-14T04:10:06+00:00","dateModified":"2026-08-14T04:10:08+00:00","description":"ACROBiosystems Co., Ltd. (SHE: 301080) and Bailinke Pharmaceutical Technology (Shanghai) Co., Ltd. have entered into a strategic partnership to establish a long\u2011term strategic relationship focused on AI\u2011empowered, next\u2011generation affinity purification ligands and affinity chromatography resins. The two companies will jointly build a next\u2011generation affinity purification solution that integrates \"upstream AI protein design + downstream affinity resins.\"","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=72499#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=72499"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=72499#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp","width":1080,"height":608,"caption":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=72499#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"ACROBiosystems and Bailinke Pharmaceutical Form Strategic Partnership to Build AI\u2011Empowered Affinity Purification Solutions"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2026\/08\/1402.webp","_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72499","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=72499"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72499\/revisions"}],"predecessor-version":[{"id":72501,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/72499\/revisions\/72501"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/72500"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=72499"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=72499"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=72499"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}